Evidence map›Paper›PMID 41011729›Full record

ArticleMolecules (Basel, Switzerland)2025

SABRE Ir-IMes Catalysis for the Masses.

Izabelle Smith, Noah Terkildsen, Zachary Bender, Abubakar Abdurraheem, Shiraz Nantogma, Anna Samoilenko, Joseph Gyesi, Larisa M Kovtunova, Oleg G Salnikov, Igor V Koptyug and 4 more

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. High-resolution microtesla in-situJournal of magnetic resonance (San Diego, Calif. : 1997) · 2026
    Article
  3. AutomatedAnalytical chemistry · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Izabelle SmithDepartment of Chemistry Biology and Health Sciences, South Dakota School of Mines & Technology, Rapid City, SD 57701, USA.ORCID 0009-0005-0239-7624
Noah TerkildsenDepartment of Chemistry Biology and Health Sciences, South Dakota School of Mines & Technology, Rapid City, SD 57701, USA.ORCID 0009-0008-5058-5373
Zachary BenderDepartment of Chemistry Biology and Health Sciences, South Dakota School of Mines & Technology, Rapid City, SD 57701, USA.ORCID 0009-0005-0216-6623
Abubakar AbdurraheemDepartment of Chemistry, Integrative Biosciences (Ibio), Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, USA.ORCID 0000-0002-3916-8834
Shiraz NantogmaDepartment of Chemistry, Integrative Biosciences (Ibio), Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, USA.ORCID 0000-0002-2655-6256
Anna SamoilenkoDepartment of Chemistry, Integrative Biosciences (Ibio), Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, USA.ORCID 0009-0002-3202-1829
Joseph GyesiDepartment of Chemistry, Integrative Biosciences (Ibio), Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, USA.ORCID 0000-0002-1672-0147
Larisa M KovtunovaInternational Tomography Center SB RAS, Novosibirsk 630090, Russia.ORCID 0000-0003-0922-6594
Oleg G SalnikovInternational Tomography Center SB RAS, Novosibirsk 630090, Russia.ORCID 0000-0003-2266-7335
Igor V KoptyugInternational Tomography Center SB RAS, Novosibirsk 630090, Russia.ORCID 0000-0003-3480-7649
Raphael KircherInstitute of Physics, Helmholtz Institute Mainz, Johannes Gutenberg Universität Mainz, 55099 Mainz, Germany.ORCID 0000-0002-7980-7995
Danila A BarskiyFrost Institute for Chemistry and Molecular Science, Department of Chemistry, University of Miami, Coral Gables, FL 33146, USA.ORCID 0000-0002-2819-7584
Eduard Y ChekmenevDepartment of Chemistry, Integrative Biosciences (Ibio), Karmanos Cancer Institute (KCI), Wayne State University, Detroit, MI 48202, USA.ORCID 0000-0002-8745-8801
Roman V ShchepinDepartment of Chemistry Biology and Health Sciences, South Dakota School of Mines & Technology, Rapid City, SD 57701, USA.ORCID 0000-0001-9135-3036

Funding

Plug-and-play Hyperpolarized MRI of Metabolism on Clinical ScannersR01EB034197 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Eduard Chekmenev, Matthew Scot Rosen · 2024 to 2026
$1.8M
Rapid low-cost production of contrast agents for metabolic imagingR21EB033872 · NIBIB · WAYNE STATE UNIVERSITY · PI CHEKMENEV, EDUARD · 2023 to 2024
$415k
NIBIB NIH HHS R01 EB034197NIBIB NIH HHS R21 EB033872NIH HHS 1R01EB034197-01NIH HHS 1R21EB033872-01NSF CHE-2404387NSF CHE-2404388Russian Science Foundation 25-13-00053South Dakota Mines startup fundingUniversity of Mainz (GE) subaward 442287
6 · The paper itself

Abstract

The Signal Amplification By Reversible Exchange (SABRE) technique provides enhancement of Nuclear Magnetic Resonance (NMR) signals up to several orders of magnitude using chemical exchange of a substrate and parahydrogen on an iridium complex. Therefore, the availability of such a catalytic complex to a broader community is an absolutely vital step for dissemination of the groundbreaking SABRE methodology. The most common SABRE catalyst, which is activated in situ, is based on Ir-IMes system (IMes = 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene). Earlier approaches for the synthesis of this catalyst often relied on specialized equipment and were limited to a comparatively small scale. This, in turn, increased the barrier of entry for new scientists to the area of SABRE hyperpolarization. Here, we present a robust, inexpensive, and easy to reproduce synthetic procedure for the preparation of this SABRE catalyst, which does not require specialized inert atmosphere equipment like a glove box or Schlenk line. The synthesis was validated on the scale of several grams vs. tens of milligrams scale in the reported approaches. The resulting SABRE catalyst, [Ir(IMes)(COD)Cl], was activated in situ and further evaluated in hyperpolarization experiments resulting in signal enhancements comparable to (or higher than) those for the catalyst prepared using Schlenk line equipment.

Indexed as

hyperpolarizationiridiumNMR spectroscopyparahydrogenSABRE

Identifiers

PMID41011729
PMCPMC12473097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.